LAPADULA, GIUSEPPE
LAPADULA, GIUSEPPE
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: Results from the Italian EPOKA-MASTER cohort
2005 Torti, C; Lapadula, G; Casari, S; Puoti, M; Nelson, M; Quiros-Roldan, E; Bella, D; Pastore, G; Ladisa, N; Minoli, L; Sotgiu, G; Mazzotta, F; Lo Caputo, S; Di Perri, G; Filice, G; Tinelli, C; Carosi, G
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naïve for lopinavir with limited exposure to previous protease inhibitors
2006 Torti, C; Uccelli, M; Quiros-Roldan, E; Gargiulo, F; Tirelli, V; Lapadula, G; Regazzi, M; Pierotti, P; Tinelli, C; Luca, A; Patroni, A; Manca, N; Carosi, G
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: Results from the EPOKA-MASTER cohort
2006 Torti, C; Lapadula, G; Puoti, M; Casari, S; Uccelli, M; Cristini, G; Bella, D; Pastore, G; Ladisa, N; Minoli, L; Sotgiu, G; Caputo, S; Bonora, S; Carosi, G
Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy
2006 Lapadula, G; Torti, C; Paraninfo, G; Castelnuovo, F; Uccelli, M; Costarelli, S; Ladisa, N; Maserati, R; Di Pietro, M; De Silvestri, A; Tinelli, C; Puoti, M; Carosi, G
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART
2006 Uccelli, M; Torti, C; Lapadula, G; Labate, L; Cologni, G; Tirelli, V; Moretti, F; Costarelli, S; Quiros-Roldan, E; Carosi, G
Dideoxynucleoside HIV reverse transcriptase inhibitors and drug-related hepatotoxicity: A case report
2007 Lapadula, G; Izzo, I; Costarelli, S; Cologni, G; Bercich, L; Casari, S; Gambarotti, M; Torti, C
CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load
2007 Torti, C; Lapadula, G; Barreiro, P; Soriano, V; Mandalia, S; De Silvestri, A; Suter, F; Maggiolo, F; Antinori, A; Antonucci, F; Maserati, R; El Hamad, I; Pierotti, P; Sighinolfi, L; Migliorino, G; Ladisa, N; Carosi, G
Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts >= 200 cells/mm(3)
2007 Lapadula, G; Torti, C; Maggiolo, F; Casari, S; Suter, F; Minoli, L; Pezzoli, C; Di Pietro, M; Migliorino, G; Quiros-Roldan, E; Ladisa, N; Sighinolfi, L; Costarelli, S; Carosi, G
Predictors of AIDS-defining events among advanced naïve patients after HAART
2007 Torti, C; Lapadula, G; Maggiolo, F; Casari, S; Suter, F; Minoli, L; Pezzoli, C; Di Pietro, M; Migliorino, G; Quiros-Roldan, E; Ladisa, N; Sighinolfi, L; Gatti, F; Carosi, G
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients
2007 Torti, C; Lapadula, G; Uccelli, M; Quiros-Roldan, E; Regazzi, M; Ladisa, N; Micheli, V; Orani, A; Patroni, A; Caputo, S; Tirelli, V; Di Giambenedetto, S; Cologni, G; Costarelli, S; Gargiulo, F; Manca, N; Carosi, G
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy
2007 Quiros-Roldan, E; Torti, C; Lapadula, G; Ladisa, N; Micheli, V; Patroni, A; Cusato, M; Pierotti, P; Tirelli, V; Uccelli, M; Di Giambenedetto, S; Castelnuovo, F; Gargiulo, F; Manca, N; Carosi, G
Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients
2007 Torti, C; Costarelli, S; De Silvestri, A; Quiros-Roldan, E; Lapadula, G; Cologni, G; Paraninfo, G; Castelnuovo, F; Puoti, M; Carosi, G
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients [2]
2007 Costarelli, S; Torti, C; Gatta, L; Tinelli, C; Lapadula, G; Quiros-Roldan, E; Izzo, I; Castelnuovo, F; Biasiotto, G; Arosio, P; Carosi, G
Screening and management of HIV-2-infected individuals in Northern Italy
2008 Costarelli, S; Torti, C; Rodella, A; Baldanti, F; Paolucci, S; Lapadula, G; Manca, N; Quiros-Roldan, E; Izzo, I; Carosi, G
Updated prevalence of genotypic resistance among HIV-1 positive patients naïve to antiretroviral therapy: A single center analysis
2008 Lapadula, G; Izzo, I; Gargiulo, F; Paraninfo, G; Castelnuovo, F; Quiros-Roldan, E; Cologni, G; Ceresoli, F; Manca, N; Carosi, G; Torti, C
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study
2008 Squillace, N; Lapadula, G; Torti, C; Orlando, G; Mandalia, S; Nardini, G; Beghetto, B; Costarelli, S; Guaraldi, G
Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naïve to antiretrovirals
2008 Torti, C; Quiros-Roldan, M; Cologni, G; Nichelatti, M; Ceresoli, F; Pinti, M; Nasi, M; Cossarizza, A; Lapadula, G; Costarelli, S; Manca, N; Gargiulo, F; Magoni, M; Carosi, G
Risk of early virological failure of once-daily tenofovir-emtricitabine plus twice-daily nevirapine in antiretroviral therapy-naive HIV-infected patients
2008 Lapadula, G; Costarelli, S; Quiros-Roldan, E; Calabresi, A; Izzo, I; Carosi, G; Torti, C
Prevalence and risk factors for etravirine resistance among patients failing on non-nucleoside reverse transcriptase inhibitors
2008 Lapadula, G; Calabresi, A; Castelnuovo, F; Costarelli, S; Quiros-Roldan, E; Paraninfo, G; Ceresoli, F; Gargiulo, F; Manca, N; Carosi, G; Torti, C
Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV
2008 Quiros-Roldan, E; Calabresi, A; Lapadula, G; Tirelli, V; Costarelli, S; Cologni, G; Zoltron, S; Puoti, M; Carosi, G; Torti, C